Published in FEBS Lett on January 02, 2004
Lack of oxygen deactivates mitochondrial complex I: implications for ischemic injury? J Biol Chem (2009) 1.10
Conformational change of mitochondrial complex I increases ROS sensitivity during ischemia. Antioxid Redox Signal (2013) 0.98
ND3, ND1 and 39kDa subunits are more exposed in the de-active form of bovine mitochondrial complex I. Biochim Biophys Acta (2014) 0.91
Characterisation of the active/de-active transition of mitochondrial complex I. Biochim Biophys Acta (2014) 0.90
Selective inhibition of deactivated mitochondrial complex I by biguanides. Biochemistry (2015) 0.88
Mitochondrial complex II prevents hypoxic but not calcium- and proapoptotic Bcl-2 protein-induced mitochondrial membrane potential loss. J Biol Chem (2010) 0.86
Ischemic A/D transition of mitochondrial complex I and its role in ROS generation. Biochim Biophys Acta (2016) 0.84
Molecular mechanism and physiological role of active-deactive transition of mitochondrial complex I. Biochem Soc Trans (2013) 0.80
Age-dependent mitochondrial energy dynamics in the mice heart: role of superoxide dismutase-2. Exp Gerontol (2013) 0.78
Effect of monovalent cations on the kinetics of hypoxic conformational change of mitochondrial complex I. Biochim Biophys Acta (2015) 0.76
Modulation of the conformational state of mitochondrial complex I as a target for therapeutic intervention. Interface Focus (2017) 0.76
Differential susceptibility of mitochondrial complex II to inhibition by oxaloacetate in brain and heart. Biochim Biophys Acta (2016) 0.75
The control of mitochondrial succinate-dependent H2O2 production. J Bioenerg Biomembr (2011) 0.75
Architecture of succinate dehydrogenase and reactive oxygen species generation. Science (2003) 4.40
Second hand smoke stimulates tumor angiogenesis and growth. Cancer Cell (2003) 2.17
Doxorubicin cardiomyopathy. Cardiology (2009) 1.99
A sphingosine kinase 1 mutation sensitizes the myocardium to ischemia/reperfusion injury. Cardiovasc Res (2007) 1.91
Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction. Am J Physiol Heart Circ Physiol (2006) 1.63
CD133 is a marker for long-term repopulating murine epidermal stem cells. J Invest Dermatol (2012) 1.58
Signals from type 1 sphingosine 1-phosphate receptors enhance adult mouse cardiac myocyte survival during hypoxia. Am J Physiol Heart Circ Physiol (2007) 1.50
Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKC epsilon knockout mouse hearts. Am J Physiol Heart Circ Physiol (2002) 1.45
Sphingosine kinase activation mediates ischemic preconditioning in murine heart. Circulation (2004) 1.44
Structural and computational analysis of the quinone-binding site of complex II (succinate-ubiquinone oxidoreductase): a mechanism of electron transfer and proton conduction during ubiquinone reduction. J Biol Chem (2005) 1.38
Cardiac transgenic matrix metalloproteinase-2 expression directly induces impaired contractility. Cardiovasc Res (2005) 1.30
A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers. Biochem J (2003) 1.29
Transgenic MMP-2 expression induces latent cardiac mitochondrial dysfunction. Biochem Biophys Res Commun (2007) 1.23
Differences among cell types in NAD(+) compartmentalization: a comparison of neurons, astrocytes, and cardiac myocytes. J Neurosci Res (2007) 1.22
Crystallographic studies of the Escherichia coli quinol-fumarate reductase with inhibitors bound to the quinol-binding site. J Biol Chem (2002) 1.22
Dimethylsphingosine and FTY720 inhibit the SK1 form but activate the SK2 form of sphingosine kinase from rat heart. J Biochem Mol Toxicol (2007) 1.21
Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning. Am J Physiol Heart Circ Physiol (2009) 1.16
Moderate alcohol consumption induces sustained cardiac protection by activating PKC-epsilon and Akt. Am J Physiol Heart Circ Physiol (2002) 1.16
A structural model for binding of the serine-rich repeat adhesin GspB to host carbohydrate receptors. PLoS Pathog (2011) 1.15
Deletion of the sphingosine kinase-1 gene influences cell fate during hypoxia and glucose deprivation in adult mouse cardiomyocytes. Cardiovasc Res (2007) 1.13
Cardiac ischemia-reperfusion injury induces matrix metalloproteinase-2 expression through the AP-1 components FosB and JunB. Am J Physiol Heart Circ Physiol (2006) 1.12
Role of sphingosine kinase activity in protection of heart against ischemia reperfusion injury. Med Sci Monit (2006) 1.11
Poly(ADP-ribose) polymerase-1 hyperactivation and impairment of mitochondrial respiratory chain complex I function in reperfused mouse hearts. Am J Physiol Heart Circ Physiol (2006) 1.10
Sphingosine can pre- and post-condition heart and utilizes a different mechanism from sphingosine 1-phosphate. J Biochem Mol Toxicol (2008) 1.07
Ischaemic postconditioning protects isolated mouse hearts against ischaemia/reperfusion injury via sphingosine kinase isoform-1 activation. Cardiovasc Res (2008) 1.07
Combined sphingosine, S1P and ischemic postconditioning rescue the heart after protracted ischemia. Biochem Biophys Res Commun (2008) 1.07
High-density lipoprotein determines adult mouse cardiomyocyte fate after hypoxia-reoxygenation through lipoprotein-associated sphingosine 1-phosphate. Am J Physiol Heart Circ Physiol (2010) 1.07
Effect of anoxia/reperfusion on the reversible active/de-active transition of NADH-ubiquinone oxidoreductase (complex I) in rat heart. Biochim Biophys Acta (2002) 1.07
Molecular determinants of responses to myocardial ischemia/reperfusion injury: focus on hypoxia-inducible and heat shock factors. Cardiovasc Res (2004) 1.06
The quinone binding site in Escherichia coli succinate dehydrogenase is required for electron transfer to the heme b. J Biol Chem (2006) 1.04
A rapid radioassay for sphingosine kinase. Anal Biochem (2005) 1.02
S1P lyase: a novel therapeutic target for ischemia-reperfusion injury of the heart. Am J Physiol Heart Circ Physiol (2011) 1.02
Pyrroloquinoline quinone preserves mitochondrial function and prevents oxidative injury in adult rat cardiac myocytes. Biochem Biophys Res Commun (2007) 0.99
Polarizability of G4-DNA observed by electrostatic force microscopy measurements. Nano Lett (2007) 0.99
High-resolution STM imaging of novel poly(G)-poly(C) DNA molecules. J Phys Chem B (2006) 0.98
Structure of Escherichia coli succinate:quinone oxidoreductase with an occupied and empty quinone-binding site. J Biol Chem (2009) 0.97
Redox-dependent change of nucleotide affinity to the active site of the mammalian complex I. Biochemistry (2007) 0.97
Escherichia coli succinate dehydrogenase variant lacking the heme b. Proc Natl Acad Sci U S A (2007) 0.97
Differences in protonation of ubiquinone and menaquinone in fumarate reductase from Escherichia coli. J Biol Chem (2006) 0.97
Active/de-active transition of respiratory complex I in bacteria, fungi, and animals. Biochim Biophys Acta (2003) 0.97
The bacterial flagellar switch complex is getting more complex. EMBO J (2008) 0.96
Comparison of pyrroloquinoline quinone and/or metoprolol on myocardial infarct size and mitochondrial damage in a rat model of ischemia/reperfusion injury. J Cardiovasc Pharmacol Ther (2006) 0.96
MnSOD in mouse heart: acute responses to ischemic preconditioning and ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol (2005) 0.95
Protein kinase C epsilon dependence of the recovery from down-regulation of S1P1 G protein-coupled receptors of T lymphocytes. J Biol Chem (2003) 0.95
N-terminal truncated intracellular matrix metalloproteinase-2 induces cardiomyocyte hypertrophy, inflammation and systolic heart failure. PLoS One (2013) 0.94
Chirality of silver nanoparticles synthesized on DNA. J Am Chem Soc (2006) 0.94
Inhibitory effect of palmitate on the mitochondrial NADH:ubiquinone oxidoreductase (complex I) as related to the active-de-active enzyme transition. Biochem J (2005) 0.94
Acute vincristine pretreatment protects adult mouse cardiac myocytes from oxidative stress. J Mol Cell Cardiol (2007) 0.94
A threonine on the active site loop controls transition state formation in Escherichia coli respiratory complex II. J Biol Chem (2008) 0.94
Electron transfer and catalytic control by the iron-sulfur clusters in a respiratory enzyme, E. coli fumarate reductase. J Am Chem Soc (2005) 0.94
Cardiomyocyte S1P1 receptor-mediated extracellular signal-related kinase signaling and desensitization. J Cardiovasc Pharmacol (2009) 0.93
Sphingolipid signaling and treatment during remodeling of the uninfarcted ventricular wall after myocardial infarction. Am J Physiol Heart Circ Physiol (2009) 0.93
Vincristine attenuates doxorubicin cardiotoxicity. Biochem Biophys Res Commun (2008) 0.93
Cardiac transgenic matrix metalloproteinase-2 expression induces myxomatous valve degeneration: a potential model of mitral valve prolapse disease. Cardiovasc Pathol (2008) 0.92
Defining the Q-site of Escherichia coli fumarate reductase by site-directed mutagenesis, fluorescence quench titrations and EPR spectroscopy. FEBS J (2005) 0.92
A novel intracellular isoform of matrix metalloproteinase-2 induced by oxidative stress activates innate immunity. PLoS One (2012) 0.92
Fumarate reductase and succinate oxidase activity of Escherichia coli complex II homologs are perturbed differently by mutation of the flavin binding domain. J Biol Chem (2006) 0.91
Low dose N, N-dimethylsphingosine is cardioprotective and activates cytosolic sphingosine kinase by a PKCepsilon dependent mechanism. Cardiovasc Res (2006) 0.91
Formation and characterization of stable human serum albumin-tris-malonic acid [C60]fullerene complex. Bioconjug Chem (2005) 0.91
A sphingosine kinase form 2 knockout sensitizes mouse myocardium to ischemia/reoxygenation injury and diminishes responsiveness to ischemic preconditioning. Oxid Med Cell Longev (2011) 0.90
Epinephrine is required for normal cardiovascular responses to stress in the phenylethanolamine N-methyltransferase knockout mouse. Circulation (2007) 0.89
Electron-transfer mechanisms through biological redox chains in multicenter enzymes. J Am Chem Soc (2002) 0.89
Molecular identification of the enzyme responsible for the mitochondrial NADH-supported ammonium-dependent hydrogen peroxide production. FEBS Lett (2010) 0.89
Pyrroloquinoline quinone (PQQ) decreases myocardial infarct size and improves cardiac function in rat models of ischemia and ischemia/reperfusion. Cardiovasc Drugs Ther (2004) 0.88
Adult cardiac fibroblasts null for sphingosine kinase-1 exhibit growth dysregulation and an enhanced proinflammatory response. J Mol Cell Cardiol (2007) 0.88
Absence of NADH channeling in coupled reaction of mitochondrial malate dehydrogenase and complex I in alamethicin-permeabilized rat liver mitochondria. Biochem Biophys Res Commun (2004) 0.88
Minocycline protects cardiac myocytes against simulated ischemia–reperfusion injury by inhibiting poly(ADP-ribose) polymerase-1. J Cardiovasc Pharmacol (2010) 0.87
The quinone-binding and catalytic site of complex II. Biochim Biophys Acta (2010) 0.87
A novel strong competitive inhibitor of complex I. FEBS Lett (2005) 0.87
Altering pyrroloquinoline quinone nutritional status modulates mitochondrial, lipid, and energy metabolism in rats. PLoS One (2011) 0.87
Assembling of G-strands into novel tetra-molecular parallel G4-DNA nanostructures using avidin-biotin recognition. Nucleic Acids Res (2008) 0.86
Topography and chemical reactivity of the active-inactive transition-sensitive SH-group in the mitochondrial NADH:ubiquinone oxidoreductase (Complex I). Biochim Biophys Acta (2006) 0.86
Expression of a Gi-coupled receptor in the heart causes impaired Ca2+ handling, myofilament injury, and dilated cardiomyopathy. Am J Physiol Heart Circ Physiol (2007) 0.84
Transgenic expression of matrix metalloproteinase-2 induces coronary artery ectasia. Int J Exp Pathol (2010) 0.84
Perturbation of the quinone-binding site of complex II alters the electronic properties of the proximal [3Fe-4S] iron-sulfur cluster. J Biol Chem (2011) 0.83
Mutation of the heme axial ligand of Escherichia coli succinate-quinone reductase: implications for heme ligation in mitochondrial complex II from yeast. Biochim Biophys Acta (2010) 0.83
Purification, crystallisation and preliminary crystallographic studies of succinate:ubiquinone oxidoreductase from Escherichia coli. Biochim Biophys Acta (2002) 0.82
Using rational screening and electron microscopy to optimize the crystallization of succinate:ubiquinone oxidoreductase from Escherichia coli. Acta Crystallogr D Biol Crystallogr (2003) 0.82
Sphingolipids in cardiovascular and cerebrovascular systems: Pathological implications and potential therapeutic targets. World J Cardiol (2013) 0.82
Structural basis for malfunction in complex II. J Biol Chem (2012) 0.82
High efficiency of a sequential recombinase-mediated cassette exchange reaction in Escherichia coli. J Mol Microbiol Biotechnol (2010) 0.82
Electron transfer within complex II. Succinate:ubiquinone oxidoreductase of Escherichia coli. J Biol Chem (2005) 0.81
Energy complexes are apparently associated with the switch-motor complex of bacterial flagella. J Mol Biol (2011) 0.81
Mono and trimethine cyanines Cyan 40 and Cyan 2 as probes for highly selective fluorescent detection of non-canonical DNA structures. J Fluoresc (2010) 0.81
Myocardial survival signaling in response to stem cell transplantation. J Am Coll Surg (2009) 0.81
Molecular analysis of recombinase-mediated cassette exchange reactions catalyzed by integrase of coliphage HK022. Res Microbiol (2008) 0.81
Lipid signalling in cardiovascular pathophysiology. Cardiovasc Res (2009) 0.81
Ammonium-dependent hydrogen peroxide production by mitochondria. FEBS Lett (2008) 0.81
Geometric restraint drives on- and off-pathway catalysis by the Escherichia coli menaquinol:fumarate reductase. J Biol Chem (2010) 0.81
Defining a direction: electron transfer and catalysis in Escherichia coli complex II enzymes. Biochim Biophys Acta (2013) 0.79
Cardioprotective activity of a novel and potent competitive inhibitor of lactate dehydrogenase. FEBS Lett (2010) 0.79